Frankfurt am Main, 02 December 2011 – Brockhaus Private Equity, an independent private equity firm focusing on mid-cap German technology leaders, announces the signing of an agreement to sell its majority stake in Biopharm GmbH (including Resorba Wundversorgung GmbH & Co. KG), a leading manufacturer and distributor of surgical sutures and collagen-based wound care products, to Advanced Medical Solutions Group plc (AMS), a leading global provider of wound care products listed on London's Alternative Investment Market (AIM) for a total cash consideration of € 63.8 million.